Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001140361-25-044958
Filing Date
2025-12-09
Accepted
2025-12-09 09:36:47
Documents
1
Effectiveness Date
2025-12-09

Document Format Files

Seq Description Document Type Size
1 S-8 POS ef20060809_s8pos.htm S-8 POS 31238
  Complete submission text file 0001140361-25-044958.txt   32302
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-237220 | Film No.: 251557811
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)